Hillsdale Investment Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.06M Buy
173,870
+17,600
+11% +$353K 0.08% 279
2025
Q4
$3.09M Sell
156,270
-2,000
-1% -$35.9K 0.09% 291
2025
Q3
$2.76M Buy
158,270
+9,570
+6% +$142K 0.08% 292
2025
Q2
$2.08M Buy
148,700
+148,300
+37,075% +$2.39M 0.08% 278
2025
Q1
$7.45K Buy
+400
New +$5.96K ﹤0.01% 502
2023
Q1
Sell
-243,800
Closed -$2.87M 555
2022
Q4
$2.87M Sell
243,800
-106,400
-30% -$1.29M 0.24% 140
2022
Q3
$4.15M Buy
+350,200
New +$5.11M 0.37% 99

Other funds holding ALHC

Hillsdale Investment Management's ALHC Position: Q1 2026 in Review

Hillsdale Investment Management increased its Alignment Healthcare (ALHC) stake by 11% in Q1 2026, buying an estimated $353K and bringing the position to 173,870 shares worth $3.06M. The position accounts for 0.08% of the portfolio, ranked #279.

Hillsdale Investment Management first reported a position in ALHC in Q3 2022 and has held it in 7 quarters since. The position peaked at $4.15M in Q3 2022. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Hillsdale Investment Management held 173,870 shares of Alignment Healthcare worth $3.06M as of Q1 2026.
  • Hillsdale Investment Management bought 17,600 Alignment Healthcare shares in Q1 2026, an estimated $353K.
  • Alignment Healthcare made up 0.08% of Hillsdale Investment Management's portfolio in Q1 2026, its #279 holding.
  • Hillsdale Investment Management first reported a position in Alignment Healthcare in Q3 2022 and has held it in 7 quarters since.
  • Hillsdale Investment Management's Alignment Healthcare position peaked at $4.15M in Q3 2022.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.